Edition:
United States

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
232,154
52-wk High
$11.08
52-wk Low
$0.80

Summary

Name Age Since Current Position

Angelos Stergiou

2017 President, Chief Executive Officer, Director

Gene Mack

2018 Chief Financial Officer, Treasurer

Nicholas Sarlis

2017 Chief Medical Officer, Senior Vice President

John Burns

2017 Vice President - Finance, Corporate Controller

David Scheinberg

2017 Director

Stephen Ghighlieri

56 2017 Independent Director

Robert Van Nostrand

2017 Independent Director

John Varian

2017 Independent Director

Jane Wasman

2017 Independent Director

Biographies

Name Description

Angelos Stergiou

Gene Mack

Mr. Gene C. Mack is Chief Financial Officer, Treasurer of the Company. Mr. Mack joins SELLAS having served as a consulting chief financial officer for a number of private and publicly traded biotechnology and pharmaceutical companies, developing strategy and leading management of all company finance, accounting, and treasury functions, most recently with Nicox, SA. Prior to consulting, Mr. Mack held finance and business development positions at Ascendia Pharmaceuticals and Edge Therapeutics. Over the past 5 years, Mr. Mack has raised over $300 million in equity and debt financing while also advising on numerous successful M&A and product licensing transactions. Mr. Mack also spent over 13 years as a senior publishing analyst in life sciences equity research at Brean Capital, Lazard, and HSBC Capital Markets. Mr. Mack began his career conducting clinical research at Columbia University College of Physicians and Surgeons. Mr. Mack holds a B.S. in Biochemistry and an M.B.A. in Finance, both from Fordham University.

Nicholas Sarlis

John Burns

David Scheinberg

Stephen Ghighlieri

Mr. Stephen F. Ghiglieri serves as Independent Director of the Company. He was Interim Chief Executive Officer, Executive Vice President, Principal Accounting Officer of the Company. Mr. Ghiglieri has served as the Chief Financial Officer since 2013 and Chief Operating Officer since 2015 at MedData, Inc. From 2003 until 2013, he served as Executive Vice President, Chief Operating Officer and Chief Financial Officer of Neurogesx, Inc. Prior to that, he was Chief Financial Officer and Corporate Secretary at Hansen Medical, Inc. from 2002 to 2003; Executive Vice President, Chief Financial Officer and Corporate Secretary at Avolent, Inc. from 2000 to 2002; Chief Financial Officer, Vice President Finance and Corporate Secretary at Andromedia, Inc. from 1999-2000; Vice President Finance and Administration, Chief Financial Officer and Corporate Secretary at Oacis Healthcre Systems, Inc. from 1994 to 1999 and Controller at Oclassen Pharmaceuticals from 1992 to 1994. From 1984 to 1992, Mr. Ghiglieri was an Audit Manager at PricewaterhouseCoopers. He received a Bachelor of Science in Business Administration from California State University, Hayward where he graduated Magna Cum Laude. Mr. Ghiglieri is also a Certified Public Accountant (inactive).

Robert Van Nostrand

John Varian

Jane Wasman